Filing Details

Accession Number:
0001104659-24-009537
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-01 17:58:54
Reporting Period:
2024-01-30
Accepted Time:
2024-02-01 17:58:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1831828 Vera Therapeutics Inc. VERA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1720685 Maha Katabi C/O Sofinnova Investments, Inc.
3000 Sand Hill Road, Bldg. 4, Suite 250
Menlo Park CA 94025
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2024-01-30 161,290 $31.00 3,628,446 No 4 P Indirect By Sofinnova Venture Partners X, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Sofinnova Venture Partners X, L.P.
Footnotes
  1. The shares are held directly by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.P. ("SM X LP") is the general partner of SVP X and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by SVP X. Sofinnova Management X-A, L.L.C. ("SM X LLC") is the general partner of SVP X LP and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by SVP X. James I. Healy and Maha Katabi are the managing members of SM X LLC and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by SVP X. Such entities and individuals each disclaim beneficial ownership of such securities, except to the extent of his, her or its proportionate pecuniary interest therein.